Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Tepezza Improves Proptosis in Patients With Chronic TED
Horizon Therapeutics has announced positive and statistically significant topline results from its randomized, double-masked, placebo-controlled Phase 4 clinical trial evaluating TEPEZZA for the treatment of adults with chronic thyroid eye disease (TED) and low CAS, a measure of disease activity.…
Targeting angiogenesis in oncology, ophthalmology and beyond – Nature
Targeting angiogenesis in oncology, ophthalmology and beyond Nature Source: Author: | Date: 2023-04-11 07:00:00 Source: Author: | Date: 2023-04-11 07:00:00
Johnson & Johnson Vision Names Regional Presidents
Johnson & Johnson Vision has announced the appointment of Lori Tierney as President, Americas; Jacqueline Henderson as President, EMEA; and Christoph Vonwiller as President, Asia Pacific. Ms. Tierney brings her experience as the former President of Americas for the Vision…
EverSight Launches Preloaded DMEK EndoGlide
Eversight, a nonprofit eye bank, announced the availability of Descemet’s membrane endothelial keratoplasty (DMEK) tissue preloaded in EndoGlide, which offers corneal surgeons an additional preloaded DMEK option, making it the fourth one, that helps in making the surgery more efficient…
Ultomiris Poised for EU Approval as NMOSD Treatment
AstraZeneca’s Ultomiris (ravulizumab) has received a recommendation for marketing authorization in the European Union (EU) for the treatment of adult patients who are anti-aquaporin-4 (AQP4) antibody positive (Ab+) and have neuromyelitis optica spectrum disorder (NMOSD). If authorized, Ultomiris would become…
WCO and Alcon to Launch Revolutionary Dry Eye Tool
The World Council of Optometry (WCO) and Alcon are extending an invitation to eye care professionals worldwide to join them at the launch of a new tool that aids in the diagnosis and treatment of dry eye disease. Interested parties…
New Fish Oil Supplement May Reverse Vision Loss
According to a recent study, scientists may have found a promising treatment for one of the leading causes of blindness worldwide. The study suggests that a new fish oil supplement could hold the key to preventing vision loss caused by…
Eyes May Offer Early Clues to Alzheimer’s Disease
Researchers at Cedars-Sinai have conducted the most comprehensive analysis of retinal changes in Alzheimer’s disease patients and their correlation with brain and cognitive changes. The findings of this study, which have been published in the journal Acta Neuropathologica, are crucial…
Positive Results for Dry AMD Treatment by LumiThera
LumiThera announced the 24-month data from its LIGHTSITE III multicenter clinical trial. The results showed sustained vision improvement in subjects with dry age-related macular degeneration (AMD) who were treated with the Valeda Light Delivery System. LumiThera conducted LIGHTSITE III, a…
Gene Therapy for Retinitis Pigmentosa Shows Promise
People with retinitis pigmentosa typically experience changes in their vision during childhood or early adulthood. The condition commonly results in a decline in both peripheral and night vision, ultimately leading to blindness in the majority of cases. A team of…